Skip to main content
. 2021 Dec 17;12:772096. doi: 10.3389/fimmu.2021.772096

Table 1.

Patient characteristics (N = 67).

Characteristics Values
Male/Female 38/29
Age at onset, y, mean ± SD 58.5 ± 13.9
Symptom at diagnosis, n (%)
Seizure 60 (89.6%)
Cognitive impairment 47 (70.1%)
Psychosis 21 (31.3%)
Consciousness disorder 9 (13.4%)
Speech disorder 4 (6.0%)
Sleep disorder 4 (6.0%)
Autonomic dysfunction 6 (9.0%)
Limb weakness 6 (9.0%)
Hyponatremia, n (%) 29 (43.3%)
CSF findings, n (%)
Cell count > 5 cells/uL 10 (14.9%)
Protein > 0.45 g/L 17 (25.4%)
Positive OB 7 (10.4%)
LGI1 antibody, n (%)
CSF positive 42 (62.7%)
Serum positive 67 (100%)
EEG, n (%)
Normal 14 (20.9%)
Epileptic 24 (35.8%)
Slow wave 8 (11.9%)
Unclear 21 (31.4%)
MRI, n (%)
Normal 34 (50.7%)
Unilateral hippocampal lesion 16 (23.9%)
Bilateral hippocampal lesions 17 (25.4%)
Tumor, n (%) 6 (9.0%)
BI upon admission, mean ± SD 80.3 ± 18.4
BI at discharge, mean ± SD 82.5 ± 20.8
mRS upon admission, median (IQR) 2 (1~3)

SD, standard deviation; CSF, cerebrospinal fluid; OB, oligoclonal band; EEG, electroencephalography; MRI, magnetic resonance imaging; BI, Barthel Index; mRS, modified Ranking scale; IQR, interquartile range.